Your session is about to expire
← Back to Search
Mindfulness for Mindfulness (COMMENCE Trial)
N/A
Waitlist Available
Led By David E Victorson, PhD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 0
Awards & highlights
COMMENCE Trial Summary
This trial is looking to improve the way self-reported mindfulness is measured in order to create a more standardized system.
COMMENCE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 0
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 0
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Mindfulness Questionnaire
COMMENCE Trial Design
1Treatment groups
Experimental Treatment
Group I: MindfulnessExperimental Treatment1 Intervention
Mindfulness
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness
2014
Completed Phase 3
~2670
Find a Location
Who is running the clinical trial?
National Institutes of Health (NIH)NIH
2,701 Previous Clinical Trials
7,498,698 Total Patients Enrolled
2 Trials studying Mindfulness
1,280 Patients Enrolled for Mindfulness
University of PittsburghOTHER
1,722 Previous Clinical Trials
16,334,794 Total Patients Enrolled
4 Trials studying Mindfulness
520 Patients Enrolled for Mindfulness
National Center for Complementary and Integrative Health (NCCIH)NIH
833 Previous Clinical Trials
661,301 Total Patients Enrolled
4 Trials studying Mindfulness
1,093 Patients Enrolled for Mindfulness
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger